AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AMN - US0017441017 - Common Stock
15.76 USD
-0.27 (-1.68%)
15.76 USD
0 (0%)
Taking everything into account, AMN scores 4 out of 10 in our fundamental rating. AMN was compared to 101 industry peers in the Health Care Providers & Services industry. AMN has only an average score on both its financial health and profitability. AMN has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
AMN had positive earnings in the past year.
AMN had a positive operating cash flow in the past year.
Of the past 5 years AMN 4 years were profitable.
In the past 5 years AMN always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -12.88%, AMN is doing worse than 77.23% of the companies in the same industry.
AMN's Return On Equity of -42.76% is on the low side compared to the rest of the industry. AMN is outperformed by 74.26% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.08%, AMN is in line with its industry, outperforming 46.53% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for AMN is above the industry average of 9.58%.
The 3 year average ROIC (13.14%) for AMN is well above the current ROIC(2.08%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROIC | 2.08% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
With a Operating Margin value of 1.65%, AMN perfoms like the industry average, outperforming 46.53% of the companies in the same industry.
In the last couple of years the Operating Margin of AMN has declined.
The Gross Margin of AMN (29.37%) is comparable to the rest of the industry.
AMN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AMN is still creating some value.
The number of shares outstanding for AMN has been increased compared to 1 year ago.
The number of shares outstanding for AMN has been reduced compared to 5 years ago.
The debt/assets ratio for AMN has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.40 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.40, AMN perfoms like the industry average, outperforming 53.47% of the companies in the same industry.
The Debt to FCF ratio of AMN is 3.80, which is a good value as it means it would take AMN, 3.80 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.80, AMN is doing good in the industry, outperforming 72.28% of the companies in the same industry.
AMN has a Debt/Equity ratio of 1.31. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.31, AMN is not doing good in the industry: 67.33% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Altman-Z | 2.4 |
ROIC/WACC0.26
WACC7.91%
2.3 Liquidity
A Current Ratio of 1.05 indicates that AMN should not have too much problems paying its short term obligations.
AMN's Current ratio of 1.05 is on the low side compared to the rest of the industry. AMN is outperformed by 69.31% of its industry peers.
A Quick Ratio of 1.05 indicates that AMN should not have too much problems paying its short term obligations.
AMN's Quick ratio of 1.05 is on the low side compared to the rest of the industry. AMN is outperformed by 62.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.29%.
The Earnings Per Share has been growing slightly by 0.80% on average over the past years.
AMN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.42%.
The Revenue has been growing slightly by 6.07% on average over the past years.
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
3.2 Future
AMN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.82% yearly.
The Revenue is expected to grow by 4.40% on average over the next years.
EPS Next Y-57.99%
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
EPS Next 5Y22.82%
Revenue Next Year-8.07%
Revenue Next 2Y-6.81%
Revenue Next 3Y-3.33%
Revenue Next 5Y4.4%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 8.34, the valuation of AMN can be described as reasonable.
Based on the Price/Earnings ratio, AMN is valued cheaper than 94.06% of the companies in the same industry.
AMN is valuated cheaply when we compare the Price/Earnings ratio to 26.77, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 20.41, AMN is valued on the expensive side.
Based on the Price/Forward Earnings ratio, AMN is valued a bit cheaper than the industry average as 60.40% of the companies are valued more expensively.
AMN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.34 | ||
| Fwd PE | 20.41 |
4.2 Price Multiples
AMN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMN is cheaper than 85.15% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AMN is valued cheaply inside the industry as 99.01% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.72 | ||
| EV/EBITDA | 6.85 |
4.3 Compensation for Growth
A cheap valuation may be justified as AMN's earnings are expected to decrease with -29.55% in the coming years.
PEG (NY)N/A
PEG (5Y)10.36
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
5. Dividend
5.1 Amount
AMN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
15.76
-0.27 (-1.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners108.78%
Inst Owner Change0.21%
Ins Owners0.43%
Ins Owner Change2.77%
Market Cap605.34M
Revenue(TTM)2.72B
Net Income(TTM)-275.54M
Analysts69.23
Price Target20.84 (32.23%)
Short Float %6.86%
Short Ratio2.58
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)-2.39%
PT rev (3m)2.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)41.93%
EPS NY rev (1m)20.88%
EPS NY rev (3m)20.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)15.48%
Revenue NY rev (1m)4.59%
Revenue NY rev (3m)4.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.34 | ||
| Fwd PE | 20.41 | ||
| P/S | 0.22 | ||
| P/FCF | 2.72 | ||
| P/OCF | 2.27 | ||
| P/B | 0.94 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.85 |
EPS(TTM)1.89
EY11.99%
EPS(NY)0.77
Fwd EY4.9%
FCF(TTM)5.8
FCFY36.81%
OCF(TTM)6.94
OCFY44.06%
SpS70.73
BVpS16.78
TBVpS-10.76
PEG (NY)N/A
PEG (5Y)10.36
Graham Number26.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROCE | 2.81% | ||
| ROIC | 2.08% | ||
| ROICexc | 2.16% | ||
| ROICexgc | 6.84% | ||
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% | ||
| FCFM | 8.2% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Debt/EBITDA | 4.12 | ||
| Cap/Depr | 27.3% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | 0.95 | ||
| Cash Conversion | 129.62% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 2.4 |
F-Score4
WACC7.91%
ROIC/WACC0.26
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
EPS Next Y-57.99%
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
Revenue Next Year-8.07%
Revenue Next 2Y-6.81%
Revenue Next 3Y-3.33%
Revenue Next 5Y4.4%
EBIT growth 1Y-66.5%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year103.44%
EBIT Next 3Y20.95%
EBIT Next 5YN/A
FCF growth 1Y-48.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-49.55%
OCF growth 3Y1.61%
OCF growth 5Y7.34%
AMN HEALTHCARE SERVICES INC / AMN FAQ
What is the fundamental rating for AMN stock?
ChartMill assigns a fundamental rating of 4 / 10 to AMN.
What is the valuation status of AMN HEALTHCARE SERVICES INC (AMN) stock?
ChartMill assigns a valuation rating of 5 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.
How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?
AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 4 / 10.
How financially healthy is AMN HEALTHCARE SERVICES INC?
The financial health rating of AMN HEALTHCARE SERVICES INC (AMN) is 4 / 10.